Skip to main content
SpringerLink
Log in

Association of Diabetes Susceptibility Gene Calpain-10 with Pancreatic Cancer Among Smokers

  • Brief Communication
  • Published:
Journal of Gastrointestinal Cancer Aims and scope Submit manuscript

Abstract

Objective

The objective of this study was to test the association between calpain-10 (CAPN10), a diabetes susceptibility gene, with risk of pancreatic cancer (PC).

Methods

DNA samples from 83 incident exocrine PC cases and 166 controls, all of whom were smokers, were genotyped for four markers of CAPN10 in a nested case–control study based on the Beta-Carotene and Retinol Efficacy Trial (CARET), a randomized chemoprevention trial of subjects at high risk of lung cancer. Controls were matched on sex, race, age, CARET intervention arm, duration of exposure to asbestos, and smoking history. Conditional logistic regression was used for statistical analyses.

Results

The minor allele of SNP-43 (rs3792267) in intron 3 was associated with increased risk of PC with an odds ratio of 1.57 (95%CI 1.03–2.38, p = 0.035) per allele. The three markers of the highest risk haplotype had an odds ratio of 1.98 (95%CI 1.12–3.49, p = 0.019) for risk of PC compared to the most common haplotype. There was no evidence of interaction between either of these associations by diabetes status.

Conclusion

These results suggest that variation in CAPN10 may be associated with increased risk of PC among smokers. Thus, studies of genes associated with diabetes risk in PC are warranted in a larger population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58:71–96.

    Article  PubMed  Google Scholar 

  2. Fesinmeyer M, Austin M, Li C, De Roos A, Bowen D. Differences in survival by histologic type of pancreatic cancer. Cancer Epidemiol Biomarkers Prev. 2005;14:1766–73.

    Article  PubMed  Google Scholar 

  3. Danaei G, Vander Hoorn S, Lopez AD, Murray CJ, Ezzati M, Comparative Risk Assessment collaborating g. Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors. Lancet. 2005;366:1784–93.

    Article  PubMed  Google Scholar 

  4. Permuth-Wey J, Egan KM. Family history is a significant risk factor for pancreatic cancer: results from a systematic review and meta-analysis. Fam Cancer. 2009;8:109–17.

    Article  PubMed  Google Scholar 

  5. Eberle M, Pfützer R, Pogue-Geile K, et al. A new susceptibility locus for autosomal dominant pancreatic cancer maps to chromosome 4q32-34. Am J Hum Genet. 2002;70:1044–8.

    Article  CAS  PubMed  Google Scholar 

  6. Pogue-Geile K, Chen R, Bronner M, et al. Palladin mutation causes familial pancreatic cancer and suggests a new cancer mechanism. PLoS Med. 2006;3:e516.

    Article  PubMed  Google Scholar 

  7. Ohnami S, Sato Y, Yoshimura K, et al. His595Tyr polymorphism in the methionine synthase reductase (MTRR) gene is associated with pancreatic cancer risk. Gastroenterology. 2008;135:477–88.

    Article  CAS  PubMed  Google Scholar 

  8. Asomaning K, Reid AE, Zhou W, et al. MDM2 promoter polymorphism and pancreatic cancer risk and prognosis. Clin Cancer Res. 2008;14:4010–5.

    Article  CAS  PubMed  Google Scholar 

  9. Yang M, Sun T, Wang L, et al. Functional variants in cell death pathway genes and risk of pancreatic cancer. Clin Cancer Res. 2008;14:3230–6.

    Article  CAS  PubMed  Google Scholar 

  10. Cowgill S, Muscarella P. The genetics of pancreatic cancer. Am J Surg. 2003;186:279–86.

    Article  CAS  PubMed  Google Scholar 

  11. Huxley R, Ansary-Moghaddam A, de Berrington González A, Barzi F, Woodward M. Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br J Cancer. 2005;92:2076–83.

    Article  CAS  PubMed  Google Scholar 

  12. Wang F, Gupta S, Holly E. Diabetes mellitus and pancreatic cancer in a population-based case–control study in the San Francisco Bay Area, California. Cancer Epidemiol Biomarkers Prev. 2006;15:1458–63.

    Article  PubMed  Google Scholar 

  13. Chari S, Leibson C, Rabe K, et al. Pancreatic cancer-associated diabetes mellitus: prevalence and temporal association with diagnosis of cancer. Gastroenterology. 2008;134:95–101.

    Article  CAS  PubMed  Google Scholar 

  14. Gapstur S, Gann P, Lowe W, Liu K, Colangelo L, Dyer A. Abnormal glucose metabolism and pancreatic cancer mortality. JAMA. 2000;283:2552–8.

    Article  CAS  PubMed  Google Scholar 

  15. Horikawa Y, Oda N, Cox N, et al. Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet. 2000;26:163–75.

    Article  CAS  PubMed  Google Scholar 

  16. Marshall C, Hitman G, Partridge C, et al. Evidence that an isoform of calpain-10 is a regulator of exocytosis in pancreatic beta-cells. Mol Endocrinol. 2005;19:213–24.

    Article  CAS  PubMed  Google Scholar 

  17. Jensen D, Urhammer S, Eiberg H, et al. Variation in CAPN10 in relation to type 2 diabetes, obesity and quantitative metabolic traits: studies in 6018 whites. Mol Genet Metab. 2006;89:360–7.

    Article  CAS  PubMed  Google Scholar 

  18. Tsuchiya T, Schwarz P, Bosque-Plata L, et al. Association of the calpain-10 gene with type 2 diabetes in Europeans: results of pooled and meta-analyses. Mol Genet Metab. 2006;89:174–84.

    Article  CAS  PubMed  Google Scholar 

  19. Fesinmeyer MD, Standford JL, Brentnall TA, et al. Association between the Peroxisome proliferator-activated receptor-gamma Pro12Ala variant and haplotype and pancreatic cancer in a high-risk cohort of smokers: a pilot study. Pancreas. 2009;38(6):631–7.

    Article  CAS  PubMed  Google Scholar 

  20. Omenn G, Goodman G, Thornquist M, et al. The beta-carotene and retinol efficacy trial (CARET) for chemoprevention of lung cancer in high risk populations: smokers and asbestos-exposed workers. Cancer Res. 1994;54:2038s–43.

    CAS  PubMed  Google Scholar 

  21. Barrett J, Fry B, Maller J, Daly M. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21:263–5.

    Article  CAS  PubMed  Google Scholar 

  22. Lin P, Vance J, Pericak-Vance M, Martin E. No gene is an island: the flip-flop phenomenon. Am J Hum Genet. 2007;80:531–8.

    Article  CAS  PubMed  Google Scholar 

  23. Zhou Y, Sreenan S, Pan C, et al. A 48-hour exposure of pancreatic islets to calpain inhibitors impairs mitochondrial fuel metabolism and the exocytosis of insulin. Metabolism. 2003;52:528–34.

    Article  CAS  PubMed  Google Scholar 

  24. Johnson J, Han Z, Otani K, et al. RyR2 and calpain-10 delineate a novel apoptosis pathway in pancreatic islets. J Biol Chem. 2004;279:24794–802.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by NIH grants R21 CA115878-01, R25 CA115878-01, U01-CA063673, and P30ES07033. Specimens were from CARET Serum Bank maintained at Fred Hutchinson Cancer Research Center (FHCRC).

Author information

Authors and Affiliations

  1. Institute for Public Health Genetics, University of Washington, Box 357236, Seattle, WA, 98195, USA

    Pui-yee Fong, Megan D. Fesinmeyer & Melissa A. Austin

  2. Department of Epidemiology, School of Public Health, University of Washington, Seattle, WA, USA

    Emily White & Melissa A. Austin

  3. Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA

    Megan D. Fesinmeyer, Emily White, Margaret T. Mandelson, Matt J. Barnett, Gary E. Goodman & Melissa A. Austin

  4. Department of Environmental and Occupational Health Sciences, School of Public Health, University of Washington, Seattle, WA, USA

    Federico M. Farin, Sengkeo Srinouanprachanh & Zahra Afsharinejad

  5. Department of Medicine, School of Medicine, University of Washington, Seattle, WA, USA

    Teresa A. Brentnall

  6. GH Center for Health Studies, Group Health Cooperative, Seattle, WA, USA

    Margaret T. Mandelson

Authors
  1. Pui-yee Fong
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Megan D. Fesinmeyer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Emily White
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Federico M. Farin
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Sengkeo Srinouanprachanh
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Zahra Afsharinejad
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Margaret T. Mandelson
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Teresa A. Brentnall
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Matt J. Barnett
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Gary E. Goodman
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Melissa A. Austin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Melissa A. Austin.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fong, Py., Fesinmeyer, M.D., White, E. et al. Association of Diabetes Susceptibility Gene Calpain-10 with Pancreatic Cancer Among Smokers. J Gastrointest Canc 41, 203–208 (2010). https://doi.org/10.1007/s12029-010-9130-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12029-010-9130-7

Keywords

Search

Navigation